AKT1 and neoplasm: The mechanism of action of β-SDG may involve the upregulation of the tumor suppressor gene miR-10a and the inactivation of the PI3K-Akt signaling pathway, leading to cell cycle arrest at the G0/G1 phase and inhibition of tumor growth and proliferation (70, 71).